Crohn's Disease Treatment Market Set for Continued Growth, Reaching $16.32 Billion by 2028
January 29, 2024 18:59 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Crohn's Disease Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest research publication on...
Global Stoma/Ostomy Care Market Report, 2022-2023 and 2024-2030 - Product Innovations and Advancements to Spur Market Expansion
January 08, 2024 07:33 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Stoma/Ostomy Care - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Stoma/Ostomy Care Products...
Stoma/Ostomy Care Global Market to Reach $5.1 Billion by 2030: Rising Incidence of Colorectal Cancer, Bladder Cancer and IBD and Drives the Need for Ostomy Care Products
March 02, 2023 11:43 ET
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Stoma/Ostomy Care: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Stoma/Ostomy...
Global Inflammatory Bowel Disease Treatment Market Research Report 2022 Featuring AbbVie, Biogen, Johnson & Johnson, Amgen, & UCB SA
November 08, 2022 06:13 ET
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease Treatment Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global inflammatory...
Global Crohn's Disease Forecast and Market Analysis Report 2020-2027 - Despite Formulary Constraints, Novel Pipeline Drugs will Expand the Market
January 12, 2021 07:03 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Crohn's Disease Forecast and Market Analysis to 2027" report has been added to ResearchAndMarkets.com's offering. As specialty products, therapies...
Lyfebulb and UnitedHealth Group Announce Winners of the 2018 Innovation Challenge for Patient Entrepreneurs
July 26, 2018 09:00 ET
|
Lyfebulb
MINNETONKA, Minn. and NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) have selected Jon Margalit of Complete Start as the winner of the first-ever Lyfebulb...
Lyfebulb and UnitedHealth Group Announce 11 Finalists for Their 2018 Innovation Challenge for Patient Entrepreneurs
June 28, 2018 09:00 ET
|
Lyfebulb
Challenge recognizes companies whose founders have been affected by inflammatory bowel disease Winners to receive monetary prizes for creative and effective solutions to address IBD MINNETONKA,...
Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease
April 23, 2018 15:18 ET
|
Lyfebulb; UnitedHealth Group
MINNETONKA, Minn. and NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) invite patient entrepreneurs to compete in “Empowering Patients: An Innovation...
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
November 06, 2014 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model
December 03, 2013 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...